Biotech company Amarantus BioSciences focuses on the development of new treatments for brain-related disorders such as Parkinson’s disease and traumatic brain injuries (TBI). The company’s efforts extend beyond the walls of a laboratory and spill onto the turf of many neurological injuries: the football field.
Earlier this year, ESPN reported that NFL players are at an unusually high risk of developing neurodegenerative diseases such as Parkinson’s disease due to the traumatic impact of multiple concussions and sub-concussive hits. This information hits particularly close to home with former Minnesota Vikings Pro Bowl linebacker E.J. Henderson, who supports further development of the Amarantus’ TBI research collaboration with Banyan Biomarkers.
“Concussions and their long-term side effects are a huge problem for NFL players and alumni,” Henderson stated in the press release. “I have been following Amarantus since they announced their collaboration with Banyan last November, and I was impressed with the initial success achieved this summer. As a result, I’ve decided to become actively involved with Amarantus in order to help bring their research to the forefront in the mainstream media. I believe these types of advances in scientific research can ultimately help current NFL players and NFL alumni who are at an unusually high risk of developing long-term side effects from multiple concussions.”
As part of his partnership with Amarantus, Henderson will work with NFL veterans Jack Brewer and Corey Chavous to raise awareness and support for Amarantus-Banyan research by utilizing the Coalition for Concussion Treatment (#C4CT) awareness campaign on Twitter, led by Brewer Sports International.
“NFL players are well aware of the risks associated with their sport, being directly affected by traumatic brain injuries on a daily basis. Many are taking an active role in supporting pertinent and relevant scientific research such as the research undertaken here at Amarantus,” said Gerald Commissiong, president & CEO of Amarantus and former professional football player with the Calgary Stampeders of the Canadian Football League. “E.J. Henderson understands the potential value and long-term benefits that our research effort could have for football players and their families. The awareness generated by the support of known athletes for our program should contribute to Amarantus’ growth, allowing us to attract capital to pursue our mission of developing new treatments for patients with brain disorders such as Parkinson’s and TBI.”
In June 2012, Amarantus announced positive data for its TBI collaboration with Banyan Biomarkers. The companies are currently working on the design of the next phase of testing Amarantus’ proprietary anti-apoptotic therapeutic protein, MANF, as a disease-modifying treatment for TBI.
For more information visit www.Amarantus.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Thursday, October 4, 2012
First Titan Corp. (FTTN) Steady Oil and Gas Flow in Alabama Undergirds a Rapidly Evolving Portfolio of Domestic Working Interests
First Titan, which has assembled five key working interests in some of the hottest domestic oil and gas regions, reported good news out of their Conecuh County, Alabama, operation at the Little Cedar Creek Field, as the new oil and gas well has been returning steady output ever since the rig was pulled off.
Daily average output for the new well has remained at around 387.5 barrels of oil (just under the 400 maximum allowed by the state), with 391.25 Mcf and no water, giving FTTN engineers a great deal of confidence, as their stabilized production outlook is further reinforced by the steady tubing pressure average of 429 psi (16/64ths choke). Shareholders will be pleased to see such a stable production profile out of the company’s first producing well with an owned interest, and the lifespan of this infrastructure looks assured, considering the current reserve estimates of around 400-800k barrels of oil.
The Little Cedar Creek Field is Alabama’s biggest producing oil field and local geology is dotted with an array of wells that have a solid production history, making the company’s working interests in Alabama some of the most exciting out of the several other working interest positions taken up via acquisitions by FTTN in the last year, most notably in emerging wells in Texas (Big Canyon Prospect), Louisiana (South Lake Charles Prospect), and Oklahoma (Gates #1 S14 Hughes County Prospect and the Breaux #2 well in Logan County). It is worth noting that the horizontal well in Logan County, OK, is engineered for completion using the revolutionary Packers Plus QuickFRAC system, which uses QuickPORT™ sleeves flanked by RockSEAL® II packers to create a first-of-its-kind solution in the industry that allows operators to do things like fracking 60 stages downhole with only 15 treatments at the surface. This is a prime example of saving massive logistical expense, while increasing productivity via technological innovation.
The company is poised for dramatic growth in domestic energy thanks to such opportunities and FTTN is committed to bringing cutting-edge drilling and production technologies to bear as the company seeks a larger leadership position in the sector. With production now steadily underway in Alabama, FTTN executives are eager to show markets similar results throughout their rapidly developing oil and gas position in the burgeoning North American energy corridor.
The company has picked up considerable WI positions in the last year and thus has plenty of opportunities to turn early investors into long-term winners via potentially lucrative drilling efforts. Investors can also feel confident in the fact that they are helping FTTN develop North America’s domestic energy infrastructure/capabilities. The company is obviously ready to meet the challenge with bold conviction, as they have over the last 12 months taken a decidedly aggressive, broad-spectrum approach to the underlying acquisition and development framework. Stable production out of Little Cedar Creek Field is a key milestone for FTTN and its shareholders can likely look forward to many more success stories like this out of the company’s portfolio, as First Titan continues to deploy their very partner-centric energy development strategy. A strategy grounded in the continuous evolution of safer, cleaner, and more efficient technologies, as well as the ability to profitably exploit unconventional resources.
FFTTN even recently announced ongoing work exploring the potential of offshore production in the Gulf of Mexico. All told, their tactical approach to putting together a successful domestic portfolio gives you a good idea of how serious these guys are about the business.
Interested parties can learn more about First Titan at the company’s Web site: www.FirstTitanEnergy.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Daily average output for the new well has remained at around 387.5 barrels of oil (just under the 400 maximum allowed by the state), with 391.25 Mcf and no water, giving FTTN engineers a great deal of confidence, as their stabilized production outlook is further reinforced by the steady tubing pressure average of 429 psi (16/64ths choke). Shareholders will be pleased to see such a stable production profile out of the company’s first producing well with an owned interest, and the lifespan of this infrastructure looks assured, considering the current reserve estimates of around 400-800k barrels of oil.
The Little Cedar Creek Field is Alabama’s biggest producing oil field and local geology is dotted with an array of wells that have a solid production history, making the company’s working interests in Alabama some of the most exciting out of the several other working interest positions taken up via acquisitions by FTTN in the last year, most notably in emerging wells in Texas (Big Canyon Prospect), Louisiana (South Lake Charles Prospect), and Oklahoma (Gates #1 S14 Hughes County Prospect and the Breaux #2 well in Logan County). It is worth noting that the horizontal well in Logan County, OK, is engineered for completion using the revolutionary Packers Plus QuickFRAC system, which uses QuickPORT™ sleeves flanked by RockSEAL® II packers to create a first-of-its-kind solution in the industry that allows operators to do things like fracking 60 stages downhole with only 15 treatments at the surface. This is a prime example of saving massive logistical expense, while increasing productivity via technological innovation.
The company is poised for dramatic growth in domestic energy thanks to such opportunities and FTTN is committed to bringing cutting-edge drilling and production technologies to bear as the company seeks a larger leadership position in the sector. With production now steadily underway in Alabama, FTTN executives are eager to show markets similar results throughout their rapidly developing oil and gas position in the burgeoning North American energy corridor.
The company has picked up considerable WI positions in the last year and thus has plenty of opportunities to turn early investors into long-term winners via potentially lucrative drilling efforts. Investors can also feel confident in the fact that they are helping FTTN develop North America’s domestic energy infrastructure/capabilities. The company is obviously ready to meet the challenge with bold conviction, as they have over the last 12 months taken a decidedly aggressive, broad-spectrum approach to the underlying acquisition and development framework. Stable production out of Little Cedar Creek Field is a key milestone for FTTN and its shareholders can likely look forward to many more success stories like this out of the company’s portfolio, as First Titan continues to deploy their very partner-centric energy development strategy. A strategy grounded in the continuous evolution of safer, cleaner, and more efficient technologies, as well as the ability to profitably exploit unconventional resources.
FFTTN even recently announced ongoing work exploring the potential of offshore production in the Gulf of Mexico. All told, their tactical approach to putting together a successful domestic portfolio gives you a good idea of how serious these guys are about the business.
Interested parties can learn more about First Titan at the company’s Web site: www.FirstTitanEnergy.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Wednesday, October 3, 2012
QualityStocks Launches Tiered Rating Service as Tool to Expose Risk and Reward Transparency
QualityStocks is pleased to announce that it has rated more than 3,000 fully reporting OTC companies as an extension of its commitment to protect investors. Taking this commitment a step further, QualityStocks has also used the information gained from tracking hundreds of online newsletter firms to measure their legitimacy.
QualityStocks has rated fully reporting OTC companies and research firms based on their investor relations and transparency practices. QualityStocks has placed these companies into one of five tiers based on their compliance with market regulations, available information, transparency to shareholders, trust within the investor community, and the value of their product and/or services: QSP (QualityStocks Partner); QSV (QualityStocks Verified); QSL (QualityStocks Limited Information); QSN (QualityStocks No Information); and Caveat Emptor (Buyer Beware).
Trading OTC stocks poses a significant risk to any investor; those investors who are successfully managing an OTC portfolio know the importance of thorough due diligence. The QualityStocks rating service is a convenient and complementary tool designed to aid a trader’s individual research.
“Transparency is absolutely critical in this market. Our team has researched each company on our list to examine their fundamentals and apply an appropriate rating,” Michael McCarthy, Managing Director of QualityStocks stated. “The result is a valuable tool that investors can use to quickly separate more trustworthy companies from more risky investments.”
To see the list of rated newsletter firms, visit: http://www.qualitystocks.net/ratings.php
To see the list of rated companies, visit: http://www.qualitystocks.net/companies.php
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
QualityStocks has rated fully reporting OTC companies and research firms based on their investor relations and transparency practices. QualityStocks has placed these companies into one of five tiers based on their compliance with market regulations, available information, transparency to shareholders, trust within the investor community, and the value of their product and/or services: QSP (QualityStocks Partner); QSV (QualityStocks Verified); QSL (QualityStocks Limited Information); QSN (QualityStocks No Information); and Caveat Emptor (Buyer Beware).
Trading OTC stocks poses a significant risk to any investor; those investors who are successfully managing an OTC portfolio know the importance of thorough due diligence. The QualityStocks rating service is a convenient and complementary tool designed to aid a trader’s individual research.
“Transparency is absolutely critical in this market. Our team has researched each company on our list to examine their fundamentals and apply an appropriate rating,” Michael McCarthy, Managing Director of QualityStocks stated. “The result is a valuable tool that investors can use to quickly separate more trustworthy companies from more risky investments.”
To see the list of rated newsletter firms, visit: http://www.qualitystocks.net/ratings.php
To see the list of rated companies, visit: http://www.qualitystocks.net/companies.php
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Terra Tech Corp. (TRTC) is “One to Watch”
Terra Tech has developed an exceptionally focused strategy for vertically integrating within the fragmented controlled environment agricultural technologies space. With an aggressive attitude to partnerships and M&A, the company is looking to grow an already strong footprint comprised of the commercial manufacturing side of the business and their wholly-owned subsidiary GrowOp Technology’s highly-visible retail brand presence. The end goal for TRTC is to become a completely integrated structure that handles everything from equipment and design, to agricultural production and product distribution.
Terra Tech is steadfastly committed to transforming the way we grow, designing offerings around both the business-to-business supplier dynamics of various commercial indoor cultivation operations and the broader retail market. The kind of localized, environmentally sustainable food production the company’s hydroponic/aeroponic solutions represent is an intriguing market for investors to look at, with sales in the disorganized specialty hydroponic retail space alone estimated at $1.2B last year. TRTC works with companies large and small to bring them the best cutting-edge hydroponic/aeroponic automated dosing-enabled architectures, complete with next-gen digital atmosphere/environmental controls, CO2 regulators, and lighting.
The recent announcement of a major deal with New Jersey-based Edible Farms (a division of Naturally Beautiful Plant Products, with over $2M in current annual revenues), firmly cements TRTC’s commercial agribusiness model. Given current gross revenue projections, the agreement between the two companies to jointly construct/operate up to 10 acres of commercial hydroponic greenhouse infrastructure on the 116-acre farm in Belvidere will rake in another $7M in annual revenues from just the first 2.5 acre facility. The future of such developments is really something to consider when you realize that almost half of all fresh retail tomatoes sold in U.S. stores today are already greenhouse produced.
The resulting 51% ownership position obtained by TRTC in the deal and the strategic position created in this key domestic market with established brand Edible Farms has tremendous shareholder upside. There are over 12k grocery retailers within a six-hour distribution window of the facility and Edible has calculated the potential local market opportunity to be in the neighborhood of $500M, a figure reinforced by increasingly strong demand for locally grown produce. This deal with Edible will really allow the strong competencies in component and overall systems design possessed by TRTC to shine through, and the agreement between the two companies will also help promote brand expansion throughout the region.
Stop for a second and think about how attractive the benefits of localized hydroponic infrastructure are, from getting rid of the need for pesticides/herbicides, to a 95% reduction in water consumption, and the ability to grow year-round, all while the distribution costs are sharply reduced or eliminated out rightly (why ship it in when you can grow it in a warehouse nearby). As attractive as the profitability of high-end hydroponic commercial produce is, President and CEO of TRTC, Derek Peterson, actually left the hectic world of being a Senior VP at Morgan Stanley Smith Barney, overseeing assets in the $100M category, to revolutionize Terra’s other market focus, indoor agricultural systems for medical cannabis.
With medical cannabis legal in 17 states and DC (11 pending), and all reasonable estimates of the total size of the national market coming in north of $100B, it is very clear that TRTC’s ability to create a one-stop-shop solution for the needs of just about any size grower can create a low-risk access point for investors within a booming sector. Fielding a growing product mix currently over 80 SKU’s (and headed for over 100), the company’s ability to deliver full-scale systems, as well as individual components that network easily, is quickly winning over retailers and growers alike. The potentially huge swathe of retail territory (over 2,400 target brick and mortar retailers identified) and the proven e-commerce visibility needed for driving organic growth, available via the company’s GrowOp, eGrow, GoodEarthHydro, and BestBuyHydro portals, collectively
represent a consumer pipeline that could alone sustain the company’s growth for years to come as the medical cannabis market continues to swell. The company has also received a great deal of highly influential press coverage, further solidifying overall identity in key demographics.
GrowOp’s intelligent approach to providing optimized nutrients, ducting and carbon filtration, environmental controllers/timers, HID/LED lighting (including Floros super HPS lamps), reflectors/ballasts, and even their portable hydroponic tents has really struck a chord with growers. The company’s commitment to pushing the design envelope in the field and something which very clearly shows the underlying systems architecture know how, is their portable hydroponic grow trailer designs, which are offered as a complete seed-to-harvest production platform. It is the bold vision inherent in such well-executed concepts that stands to lead TRTC towards their goal of consolidating a large portion of the relevant market space and vertically integrating under their model.
Top of the line technology offerings designed to make the grower’s job painless will continue to set the company apart, like their most recently launched series of environmental controllers/timers, ranging from the Chrono timers up to the flagship ATMOS-D1, a deluxe digital atmosphere controller with one of the best sensor packages on the market today. The investment needed to farm indoors in vertically spaced, tightly controlled conditions is being made an increasingly affordable possibility thanks to TRTC, and the ease of implementation is sped along by dedicated customer service personnel who work directly with customers to ensure the proper solution set is achieved for their specific requirements. That personal touch and an aggressive M&A/partnering attitude is set to serve shareholders well as Terra continues to drive forward.
For more information on Terra Tech, please visit the company’s website at: www.TerraTechCorp.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Terra Tech is steadfastly committed to transforming the way we grow, designing offerings around both the business-to-business supplier dynamics of various commercial indoor cultivation operations and the broader retail market. The kind of localized, environmentally sustainable food production the company’s hydroponic/aeroponic solutions represent is an intriguing market for investors to look at, with sales in the disorganized specialty hydroponic retail space alone estimated at $1.2B last year. TRTC works with companies large and small to bring them the best cutting-edge hydroponic/aeroponic automated dosing-enabled architectures, complete with next-gen digital atmosphere/environmental controls, CO2 regulators, and lighting.
The recent announcement of a major deal with New Jersey-based Edible Farms (a division of Naturally Beautiful Plant Products, with over $2M in current annual revenues), firmly cements TRTC’s commercial agribusiness model. Given current gross revenue projections, the agreement between the two companies to jointly construct/operate up to 10 acres of commercial hydroponic greenhouse infrastructure on the 116-acre farm in Belvidere will rake in another $7M in annual revenues from just the first 2.5 acre facility. The future of such developments is really something to consider when you realize that almost half of all fresh retail tomatoes sold in U.S. stores today are already greenhouse produced.
The resulting 51% ownership position obtained by TRTC in the deal and the strategic position created in this key domestic market with established brand Edible Farms has tremendous shareholder upside. There are over 12k grocery retailers within a six-hour distribution window of the facility and Edible has calculated the potential local market opportunity to be in the neighborhood of $500M, a figure reinforced by increasingly strong demand for locally grown produce. This deal with Edible will really allow the strong competencies in component and overall systems design possessed by TRTC to shine through, and the agreement between the two companies will also help promote brand expansion throughout the region.
Stop for a second and think about how attractive the benefits of localized hydroponic infrastructure are, from getting rid of the need for pesticides/herbicides, to a 95% reduction in water consumption, and the ability to grow year-round, all while the distribution costs are sharply reduced or eliminated out rightly (why ship it in when you can grow it in a warehouse nearby). As attractive as the profitability of high-end hydroponic commercial produce is, President and CEO of TRTC, Derek Peterson, actually left the hectic world of being a Senior VP at Morgan Stanley Smith Barney, overseeing assets in the $100M category, to revolutionize Terra’s other market focus, indoor agricultural systems for medical cannabis.
With medical cannabis legal in 17 states and DC (11 pending), and all reasonable estimates of the total size of the national market coming in north of $100B, it is very clear that TRTC’s ability to create a one-stop-shop solution for the needs of just about any size grower can create a low-risk access point for investors within a booming sector. Fielding a growing product mix currently over 80 SKU’s (and headed for over 100), the company’s ability to deliver full-scale systems, as well as individual components that network easily, is quickly winning over retailers and growers alike. The potentially huge swathe of retail territory (over 2,400 target brick and mortar retailers identified) and the proven e-commerce visibility needed for driving organic growth, available via the company’s GrowOp, eGrow, GoodEarthHydro, and BestBuyHydro portals, collectively
represent a consumer pipeline that could alone sustain the company’s growth for years to come as the medical cannabis market continues to swell. The company has also received a great deal of highly influential press coverage, further solidifying overall identity in key demographics.
GrowOp’s intelligent approach to providing optimized nutrients, ducting and carbon filtration, environmental controllers/timers, HID/LED lighting (including Floros super HPS lamps), reflectors/ballasts, and even their portable hydroponic tents has really struck a chord with growers. The company’s commitment to pushing the design envelope in the field and something which very clearly shows the underlying systems architecture know how, is their portable hydroponic grow trailer designs, which are offered as a complete seed-to-harvest production platform. It is the bold vision inherent in such well-executed concepts that stands to lead TRTC towards their goal of consolidating a large portion of the relevant market space and vertically integrating under their model.
Top of the line technology offerings designed to make the grower’s job painless will continue to set the company apart, like their most recently launched series of environmental controllers/timers, ranging from the Chrono timers up to the flagship ATMOS-D1, a deluxe digital atmosphere controller with one of the best sensor packages on the market today. The investment needed to farm indoors in vertically spaced, tightly controlled conditions is being made an increasingly affordable possibility thanks to TRTC, and the ease of implementation is sped along by dedicated customer service personnel who work directly with customers to ensure the proper solution set is achieved for their specific requirements. That personal touch and an aggressive M&A/partnering attitude is set to serve shareholders well as Terra continues to drive forward.
For more information on Terra Tech, please visit the company’s website at: www.TerraTechCorp.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Biostar Pharmaceuticals, Inc. (BSPM) Signs Agreement to Manufacture and Supply Three New Drugs to Xijing Military Hospital
Biostar Pharmaceuticals has announced that on Sept. 24, the company signed a one-year agreement to manufacture and supply three new drugs to Xijing Hospital: Gastritis Granule, Pharyngitis Granule, and Nasosinusitis Granule.
Valued at approximately $3.6 million (RMB 24 million), the agreement will take effect this month. Beginning in October, Biostar will deliver its first monthly supply (valued at around $0.3 million, or RMB 2 million) to Xijing Hospital. To be sold exclusively at Xijing Hospital, the three drugs will be given to patients admitted to the hospital for treatment. Gastritis Granule is used for the treatment of chronic and atrophic gastritis; Pharyngitis Granule is used for the treatment of acute and chronic throat inflammation; and Nasosinusitis Granule is used for the treatment of acute and chronic sinusitis.
A military hospital managed by The Fourth Military Medical University (FMMU), Xijing Hospital is one of China’s prominent military medical universities and research centers. Notably, Biostar was chosen as one of only nine pharmaceutical companies in China to work with FMMU in the fields of research and product development. Since being selected, Biostar has been working closely with FMMU’s staff to implement experimental product tests covered under the corporation agreement, including tests for Gastritis Granule, Pharyngitis Granule, and Nasosinusitis Granule.
Biostar was able to speedily and successfully complete experimental tests and trial production for all three products. Once the products passed manufacturing technology and quality inspections, the company purchased raw materials to begin production and is currently manufacturing all three drugs to be sold exclusively to Xijing Hospital, in accordance with the agreement.
Biostar will continue working with FMMU’s staff to share resources and ideas and to carry out clinical trials for other new products, which will aid the company in becoming a production base for manufacturing drugs specifically to meet the needs of China’s military. The company hopes to further expand its relationship with Xijing Hospital for more than a dozen other new drugs, which Biostar currently has technology to manufacture at its facilities.
Biostar Pharmaceuticals, through its wholly owned subsidiary and controlled affiliate in China, is engaged in developing, manufacturing, and marketing pharmaceutical and health supplement products for various diseases and conditions. Xin Aoxing Oleanolic Acid Capsule, an OTC medicine for treating chronic hepatitis B, is the company’s lead product.
For more information, visit the company’s Web site at www.biostarpharmaceuticals.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Valued at approximately $3.6 million (RMB 24 million), the agreement will take effect this month. Beginning in October, Biostar will deliver its first monthly supply (valued at around $0.3 million, or RMB 2 million) to Xijing Hospital. To be sold exclusively at Xijing Hospital, the three drugs will be given to patients admitted to the hospital for treatment. Gastritis Granule is used for the treatment of chronic and atrophic gastritis; Pharyngitis Granule is used for the treatment of acute and chronic throat inflammation; and Nasosinusitis Granule is used for the treatment of acute and chronic sinusitis.
A military hospital managed by The Fourth Military Medical University (FMMU), Xijing Hospital is one of China’s prominent military medical universities and research centers. Notably, Biostar was chosen as one of only nine pharmaceutical companies in China to work with FMMU in the fields of research and product development. Since being selected, Biostar has been working closely with FMMU’s staff to implement experimental product tests covered under the corporation agreement, including tests for Gastritis Granule, Pharyngitis Granule, and Nasosinusitis Granule.
Biostar was able to speedily and successfully complete experimental tests and trial production for all three products. Once the products passed manufacturing technology and quality inspections, the company purchased raw materials to begin production and is currently manufacturing all three drugs to be sold exclusively to Xijing Hospital, in accordance with the agreement.
Biostar will continue working with FMMU’s staff to share resources and ideas and to carry out clinical trials for other new products, which will aid the company in becoming a production base for manufacturing drugs specifically to meet the needs of China’s military. The company hopes to further expand its relationship with Xijing Hospital for more than a dozen other new drugs, which Biostar currently has technology to manufacture at its facilities.
Biostar Pharmaceuticals, through its wholly owned subsidiary and controlled affiliate in China, is engaged in developing, manufacturing, and marketing pharmaceutical and health supplement products for various diseases and conditions. Xin Aoxing Oleanolic Acid Capsule, an OTC medicine for treating chronic hepatitis B, is the company’s lead product.
For more information, visit the company’s Web site at www.biostarpharmaceuticals.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
MusclePharm Corp. (MSLP) Wins Multiple Bodybuilding.com Awards; Fitness Enthusiasts Praise Nutritional Supplements
MusclePharm, a healthy lifestyle company that develops and manufactures nutritional supplements, announced this morning that it has been awarded three of the 23 top honors at the 2012 Bodybuilding.com Supplement Awards, awarded last week at the 2012 Joe Weider’s Olympia in Las Vegas, Nevada.
The awards reflected votes casted by consumers, with over 500 brand names and more than 8,000 health and fitness products competing for recognition. The original 70 nominations this year were based on sales, and consumers voted from July 13 – August 31, 2012, in picking this year’s final winners. According to today’s press release, there were a record-breaking number of votes totaling 2.4 million.
The awards won by MusclePharm include:
• Brand Of the Year
• Pre-Workout Supplement Of the Year (AssaultTM)
• Packaging of the Year
“MusclePharm is especially gratified to receive these prestigious awards, because workout enthusiasts cast the votes for what they feel are the best products,” stated MusclePharm Chief Executive Officer Brad Pyatt. “We were honored to win these three awards, and with a field of over 8,000 supplements—235 different pre-workout products challenging our Assault™ pre-workout alone—we are proud to be a standout brand in the eyes of the consuming public. To our customers, a big thanks from the entire MP Team!”
For additional information, visit the company’s website at www.MusclePharm.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The awards reflected votes casted by consumers, with over 500 brand names and more than 8,000 health and fitness products competing for recognition. The original 70 nominations this year were based on sales, and consumers voted from July 13 – August 31, 2012, in picking this year’s final winners. According to today’s press release, there were a record-breaking number of votes totaling 2.4 million.
The awards won by MusclePharm include:
• Brand Of the Year
• Pre-Workout Supplement Of the Year (AssaultTM)
• Packaging of the Year
“MusclePharm is especially gratified to receive these prestigious awards, because workout enthusiasts cast the votes for what they feel are the best products,” stated MusclePharm Chief Executive Officer Brad Pyatt. “We were honored to win these three awards, and with a field of over 8,000 supplements—235 different pre-workout products challenging our Assault™ pre-workout alone—we are proud to be a standout brand in the eyes of the consuming public. To our customers, a big thanks from the entire MP Team!”
For additional information, visit the company’s website at www.MusclePharm.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Sauer Energy, Inc. (SENY) Video Chart for Wednesday, October 3, 2012
SENY is at a decision point. After a run to 39 cents in August, the stock has trickled back to 23 cents and is trying to hold above the 50 day simple moving average. Tuesday’s green close has the stock looking to climb, but it will face some resistance at the 25 cent mark.
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Posts (Atom)
